JPS5951223A - 製剤組成物 - Google Patents

製剤組成物

Info

Publication number
JPS5951223A
JPS5951223A JP16288482A JP16288482A JPS5951223A JP S5951223 A JPS5951223 A JP S5951223A JP 16288482 A JP16288482 A JP 16288482A JP 16288482 A JP16288482 A JP 16288482A JP S5951223 A JPS5951223 A JP S5951223A
Authority
JP
Japan
Prior art keywords
water
coated
soluble
polymer
polymeric substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16288482A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0456006B2 (es
Inventor
Masatake Miura
三浦　正剛
Kazutoshi Toya
戸矢　和利
Takayoshi Mitsunaga
光長　孝義
Hisao Tohiki
戸引　久雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP16288482A priority Critical patent/JPS5951223A/ja
Publication of JPS5951223A publication Critical patent/JPS5951223A/ja
Publication of JPH0456006B2 publication Critical patent/JPH0456006B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
JP16288482A 1982-09-17 1982-09-17 製剤組成物 Granted JPS5951223A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16288482A JPS5951223A (ja) 1982-09-17 1982-09-17 製剤組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16288482A JPS5951223A (ja) 1982-09-17 1982-09-17 製剤組成物

Publications (2)

Publication Number Publication Date
JPS5951223A true JPS5951223A (ja) 1984-03-24
JPH0456006B2 JPH0456006B2 (es) 1992-09-07

Family

ID=15763087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16288482A Granted JPS5951223A (ja) 1982-09-17 1982-09-17 製剤組成物

Country Status (1)

Country Link
JP (1) JPS5951223A (es)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
JP2000516637A (ja) * 1997-05-30 2000-12-12 ラボラトリオス・フェニックス・ユー・エス・エイ・インコーポレイテッド 多層浸透デバイス
JP2005520783A (ja) * 2001-08-06 2005-07-14 ユーロ−セルティーク エス．エイ． 治療薬と逆作用剤を含む経口用製剤
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2010035656A1 (ja) * 2008-09-29 2010-04-01 リンテック株式会社 経口投与剤
JP2011057712A (ja) * 1998-11-04 2011-03-24 Mayne Pharma Plc アデノシンアナログの経口投与

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
JP2000516637A (ja) * 1997-05-30 2000-12-12 ラボラトリオス・フェニックス・ユー・エス・エイ・インコーポレイテッド 多層浸透デバイス
JP2011057712A (ja) * 1998-11-04 2011-03-24 Mayne Pharma Plc アデノシンアナログの経口投与
JP2005520783A (ja) * 2001-08-06 2005-07-14 ユーロ−セルティーク エス．エイ． 治療薬と逆作用剤を含む経口用製剤
JP2009132711A (ja) * 2001-08-06 2009-06-18 Euro-Celtique Sa 治療薬と逆作用剤を含む経口用製剤
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2010035656A1 (ja) * 2008-09-29 2010-04-01 リンテック株式会社 経口投与剤
JPWO2010035656A1 (ja) * 2008-09-29 2012-02-23 リンテック株式会社 経口投与剤

Also Published As

Publication number Publication date
JPH0456006B2 (es) 1992-09-07

Similar Documents

Publication Publication Date Title
JP2657057B2 (ja) 二重壁で被覆した医薬のマイクロカプセルからなる徐放性薬剤
JPH09500866A (ja) 多粒状物の脈動性投薬システム
JP3350559B2 (ja) 活性成分を含有する予め成形された微小粒子より製造される機械的に安定でかつ容易に分解し得る錠剤
DE19940944B4 (de) Retardierte, orale, pharmazeutische Darreichungsformen
US5478573A (en) Delayed, sustained-release propranolol pharmaceutical preparation
ES2606463T3 (es) Combinación de formas de dosificación de levodopa/carbidopa de liberación inmediata y liberación controlada
US6455052B1 (en) Enteric coating, comprising alginic acid, for an oral preparation
KR100337985B1 (ko) 아스테미졸및슈도에페드린의서방성필름-코팅정제
CA2556514C (en) Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
JP2019504885A (ja) コレスチラミンペレット剤及びその調製のための方法
HRP960554A2 (en) Pharmaceutical formulations
NZ517465A (en) Controlled release pellet formulation
JPS6327424A (ja) 徐放性製剤およびその製造法
JPH07505126A (ja) 放出持続性ジルチアゼム製剤
JP2019527223A (ja) 耐酸性カプセル剤
WO2009002416A1 (en) Controlled release tamsulosin hydrochloride formulation
CN1124140A (zh) 口服延缓释放的曲美他嗪药物组合物
US6197347B1 (en) Oral dosage for the controlled release of analgesic
MX2011005752A (es) Composicion de liberacion pulsatil de sildenafil y proceso para prepararla.
JPS5951223A (ja) 製剤組成物
JP4558207B2 (ja) クロモン腸内遊離製剤
JP4660192B2 (ja) スフェロイド、その製造方法および医薬組成物
JP2001500150A (ja) ［Ｒ―（Ｚ）］―α―（メトキシイミノ）―α―（１―アザビシクロ［２．２．２］オクト―３―イル）アセトニトリル一塩酸塩の制御放出投与形態
MX2007012763A (es) Composiciones de liberacion controlada que comprenden una cefalosporina para el tratamiento de infeccion bacteriana.
Sharma et al. Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography